| 替罗非班对急性ST段抬高型心肌梗死并糖尿病患者急诊经皮冠状动脉介入治疗术后血清MMP-9水平的影响及临床意义 |
| |
| 引用本文： | 邓少雄,郭南鸥,郑渊,黄文森.替罗非班对急性ST段抬高型心肌梗死并糖尿病患者急诊经皮冠状动脉介入治疗术后血清MMP-9水平的影响及临床意义[J].中国临床药理学与治疗学,2011,27(7):807-811. |
| |
| 作者姓名： | 邓少雄 郭南鸥 郑渊 黄文森 |
| |
| 作者单位： | 1. 福建省泉州医学高等专科学校内科教研室,泉州,362000,福建
2. 福建医科大学附属泉州市第一医院心内科,泉州,362000,福建 |
| |
| 基金项目： | 泉州市科技局基金资助项目 |
| |
| 摘 要： | 目的:探讨替罗非班对急性ST段抬高型心肌梗死(STEMI)并糖尿病患者急诊经皮冠状动脉介入治疗(PCI)术后血清基质金属蛋白酶-9(MMP-9)水平的影响及临床意义。方法:急诊PCI治疗的STEMI并糖尿病患者123例,分为常规治疗组61例和替罗非班组62例。分别比较两组患者一般临床资料及冠状动脉病变情况,比较两组患者急诊PCI术前及术后的血清MMP-9水平,比较两组患者在PCI术后12个月冠状动脉支架内再狭窄的发生率。结果:两组患者一般临床资料、冠状动脉病变狭窄程度和病变血管数目差异均无统计学意义(P>0.05);两组患者PCI术后血清MMP-9水平较术前明显增高,差异有统计学意义(P<0.05);替罗非班组在PCI术后MMP-9水平与常规治疗组比较明显降低,差异有统计学意义(P<0.05);在PCI术后替罗非班组支架内再狭窄发生率低,与常规治疗组比较差异有统计学意义(P<0.05)。结论:STEMI并糖尿病患者急诊PCI术后血清MMP-9水平增高,替罗非班能通过降低MMP-9的表达来降低患者支架植入术后再狭窄的发生率。
|
| 关 键 词： | 替罗非班 心肌梗死 糖尿病 经皮冠状动脉介入治疗 基质金属蛋白酶-9 |
Effect and clinical significance of tirofiban on serum matrix metalloproteinase 9 after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction and diabetes |
| |
| DENG Shao-xiong,GUO Nan-ou,ZHENG-Yuan,HUANG Wen-sen.Effect and clinical significance of tirofiban on serum matrix metalloproteinase 9 after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction and diabetes[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2011,27(7):807-811. |
| |
| Authors: | DENG Shao-xiong GUO Nan-ou ZHENG-Yuan HUANG Wen-sen |
| |
| Institution: | DENG Shao-xiong1,GUO Nan-ou2,ZHENG-Yuan1,HUANG Wen-sen1 1Medical Department of Quanzhou Medical College,Quanzhou 362000,Fujian,China,2Department of Heart Internal Medicine,Affiliated the First Hospital of Quanzhou,Fujian Medical University |
| |
| Abstract: | AIM: To study the effect and clinical significance of tirofiban on serum matrix metalloproteinase 9(MMP-9) and after primary percutaneous coronary intervention(PCI) in patients with acute ST-segment elevation myocardial infarction(STEMI)and diabetes. METHODS: One hundred and twenty-three patients with acute STEMI and diabetes who were treated with primary PCI were designed into two groups: routine treatment group(61 cases) and tirofiban group(62cases).The clinical datas and coronary arterydisorders datas in... |
| |
| Keywords: | Tirofiban Myocardial infarction Diabetes Primary percutaneous coronary intervention Matrix metalloproteinase-9 |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
